Article info

This article has a correction. Please see:

Download PDFPDF

Extended report
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Authors

  1. Correspondence to Dr Joachim Sieper, Charité, Campus Benjamin Franklin, Med Clinic I, Rheumatology, Hindenburgdamm 30, 12200 Berlin, Germany; joachim.sieper{at}charite.de
View Full Text

Citation

Song I, Hermann K, Haibel H, et al
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Publication history

  • Accepted November 1, 2010
  • First published March 3, 2011.
Online issue publication 
November 02, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.